Terms: = Germ cell tumor AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
727 results:
1. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
2. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract] [Full Text] [Related]
3. The mdm2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem cells.
Nakagawa-Saito Y; Mitobe Y; Togashi K; Suzuki S; Sugai A; Takenouchi S; Nakamura K; Sonoda Y; Kitanaka C; Okada M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612758
[TBL] [Abstract] [Full Text] [Related]
4. Evolution of Testicular germ cell tumors in the Molecular Era With Histogenetic Implications.
Kilic I; Acosta AM; Idrees MT
Adv Anat Pathol; 2024 May; 31(3):206-214. PubMed ID: 38525515
[TBL] [Abstract] [Full Text] [Related]
5. An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting mdm2 for retinoblastoma.
Wang S; Zhao Y; Yao F; Wei P; Ma L; Zhang S
Biomed Pharmacother; 2024 May; 174():116437. PubMed ID: 38522240
[TBL] [Abstract] [Full Text] [Related]
6. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
7. Genetic and histological analysis intraplacental choriocarcinoma: a case report.
Takano N; Takamura M; Mizuno Y; Mizuno Y; Tamaru S; Nakamura K; Soma H; Kajihara T
Med Mol Morphol; 2024 Jun; 57(2):147-154. PubMed ID: 38421457
[TBL] [Abstract] [Full Text] [Related]
8. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma.
Wang Z; Liang X; Yi G; Wu T; Sun Y; Zhang Z; Fu M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1933. PubMed ID: 38321787
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic model for assessing the human glioma cell malignancy grade based on mdm2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
11. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Tateishi K; Miyake Y; Nakamura T; Iwashita H; Hayashi T; Oshima A; Honma H; Hayashi H; Sugino K; Kato M; Satomi K; Fujii S; Komori T; Yamamoto T; Cahill DP; Wakimoto H
Acta Neuropathol Commun; 2023 Nov; 11(1):186. PubMed ID: 38012788
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology.
Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD
Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028
[TBL] [Abstract] [Full Text] [Related]
13. Three-Dimensional Gene Regulation Network in Glioblastoma Ferroptosis.
Liu M; Wang W; Zhang H; Bi J; Zhang B; Shi T; Su G; Zheng Y; Fan S; Huang X; Chen B; Song Y; Zhao Z; Shi J; Li P; Lu W; Zhang L
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834393
[TBL] [Abstract] [Full Text] [Related]
14. Delivery versus Potency in Treating Brain tumors: BI-907828, a mdm2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma.
Zhang W; Vaubel RA; Oh JH; Mladek AC; Talele S; Zhang W; Waller KL; Burgenske DM; Sarkaria JN; Elmquist WF
Mol Cancer Ther; 2024 Jan; 23(1):47-55. PubMed ID: 37828724
[TBL] [Abstract] [Full Text] [Related]
15. USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
Le Clorennec C; Lee K; Huo Y; Zage PE
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762082
[TBL] [Abstract] [Full Text] [Related]
16. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG.
Miranda J; Vázquez-Blomquist D; Bringas R; Fernandez-de-Cossio J; Palenzuela D; Novoa LI; Bello-Rivero I
BMC Cancer; 2023 Aug; 23(1):806. PubMed ID: 37644431
[TBL] [Abstract] [Full Text] [Related]
17. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma cell Chemotherapeutic Responsiveness.
Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
[TBL] [Abstract] [Full Text] [Related]
18. Nuclear transport surveillance of p53 by nuclear pores in glioblastoma.
Ikliptikawati DK; Hirai N; Makiyama K; Sabit H; Kinoshita M; Matsumoto K; Lim K; Meguro-Horike M; Horike SI; Hazawa M; Nakada M; Wong RW
Cell Rep; 2023 Aug; 42(8):112882. PubMed ID: 37552992
[TBL] [Abstract] [Full Text] [Related]
19. GSG2 facilitates the progression of human breast cancer through mdm2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract] [Full Text] [Related]
20. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
[TBL] [Abstract] [Full Text] [Related]
[Next]